How to Get a Prescription for Ozempic for Weight Loss

Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, originally developed for type 2 diabetes, has shown remarkable results for weight loss in clinical trials—with patients losing 15% of body weight on average over 68 weeks. If you're considering this medication, understanding how to obtain a prescription and what to expect can help you make an informed decision about your weight loss journey.

Understanding Semaglutide and Weight Loss Eligibility

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that works by slowing digestion, increasing feelings of fullness, and helping regulate blood sugar levels. Most candidates for semaglutide weight loss therapy have a BMI of 30 or higher, or a BMI of 27 or higher with weight-related health conditions such as high blood pressure or prediabetes. Your provider will review your complete medical history, current medications, and any previous weight loss attempts to determine if semaglutide is appropriate for you.

Common reasons providers recommend semaglutide include difficulty losing weight through diet and exercise alone, metabolic factors affecting appetite control, and a medical need to reduce weight-related health risks. Patients with a personal or family history of thyroid cancer or multiple endocrine neoplasia type 2 (MEN 2) are typically not candidates. Your provider will also screen for contraindications and discuss whether semaglutide fits into your overall health goals.

How to Start a Semaglutide Prescription Through PlexusDx

PlexusDx connects you with licensed healthcare providers who specialize in GLP-1 weight loss therapy through a streamlined telehealth process. After completing your health intake form and having a consultation with a provider, they will write a prescription if semaglutide is medically appropriate for your situation. PlexusDx then fills your prescription at a licensed 503A compounding pharmacy, ensuring pharmaceutical quality and consistency.

The entire process typically takes 3–5 business days from consultation to receiving your first shipment. PlexusDx serves all 50 states, requires no insurance, and charges a flat monthly fee at $189/mo month-to-month, or from $149/mo on the 6-month plan for compounded semaglutide injection—your dose may need to go up, but your price won't. HSA and FSA accounts are eligible for PlexusDx medications, making treatment financially accessible for most patients.

Compounded vs. Brand-Name Semaglutide: What's the Difference

Brand-name semaglutide (Ozempic for diabetes, Wegovy for weight loss) is manufactured by Novo Nordisk and typically requires insurance coverage or out-of-pocket costs exceeding $900 per month. PlexusDx offers compounded semaglutide prepared by licensed 503A compounding pharmacies, which are regulated by state pharmacy boards and the FDA. Compounded medications contain the same active pharmaceutical ingredient but are prepared in smaller batches, often at a fraction of the brand-name price.

Both compounded and brand-name semaglutide contain identical semaglutide molecules and work the same way in your body. The key difference is sourcing and manufacturing: compounded medications are legal, regulated, and appropriate for patients who need affordable access or cannot tolerate certain inactive ingredients in brand formulations. PlexusDx ensures quality by partnering exclusively with licensed 503A compounders, never 503B facilities.

Personalized Treatment: Genetic Testing and Dose Optimization

Not all patients respond identically to semaglutide—genetics play a significant role in how your body processes GLP-1 medications and how much benefit you'll experience. PlexusDx offers the Precision Peptide Genetic Test, a peptide-pathway analysis that examines key genetic variants including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313. This test maps your individual response across 14 metabolic pathways and 49 peptides, providing 150+ genetic insights to guide your treatment.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

Do I need insurance to get a semaglutide prescription from PlexusDx?

No. PlexusDx requires no insurance and no membership fee. Medications are available in all 50 states and priced as flat monthly subscriptions at $189/mo month-to-month, or from $149/mo on the 6-month plan for compounded semaglutide injection, with HSA and FSA eligibility available.

How much weight can I expect to lose on semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Is compounded semaglutide from PlexusDx safe and effective?

Yes. PlexusDx partners only with licensed 503A compounding pharmacies regulated by state boards and the FDA. Compounded semaglutide contains the identical active ingredient as brand-name formulations and is legal, safe, and effective for weight loss.

What are the most common side effects of semaglutide for weight loss?

Common side effects include mild nausea, constipation, diarrhea, and reduced appetite—most resolve within 2–4 weeks. Serious side effects are rare but can include pancreatitis and gallbladder issues. Your PlexusDx provider will monitor you and adjust your dose as needed.

What is the Precision Peptide Genetic Test and how does it help?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.